BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 22718773)

  • 1. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Taur Y; Xavier JB; Lipuma L; Ubeda C; Goldberg J; Gobourne A; Lee YJ; Dubin KA; Socci ND; Viale A; Perales MA; Jenq RR; van den Brink MR; Pamer EG
    Clin Infect Dis; 2012 Oct; 55(7):905-14. PubMed ID: 22718773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection.
    Montassier E; Al-Ghalith GA; Ward T; Corvec S; Gastinne T; Potel G; Moreau P; de la Cochetiere MF; Batard E; Knights D
    Genome Med; 2016 Apr; 8(1):49. PubMed ID: 27121964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.
    Taur Y; Jenq RR; Perales MA; Littmann ER; Morjaria S; Ling L; No D; Gobourne A; Viale A; Dahi PB; Ponce DM; Barker JN; Giralt S; van den Brink M; Pamer EG
    Blood; 2014 Aug; 124(7):1174-82. PubMed ID: 24939656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.
    Ubeda C; Taur Y; Jenq RR; Equinda MJ; Son T; Samstein M; Viale A; Socci ND; van den Brink MR; Kamboj M; Pamer EG
    J Clin Invest; 2010 Dec; 120(12):4332-41. PubMed ID: 21099116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria.
    Stoma I; Littmann ER; Peled JU; Giralt S; van den Brink MRM; Pamer EG; Taur Y
    Clin Infect Dis; 2021 Dec; 73(11):e4627-e4635. PubMed ID: 31976518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.
    Ford CD; Lopansri BK; Gazdik MA; Snow GL; Webb BJ; Konopa KL; Petersen FB
    Transpl Infect Dis; 2015 Oct; 17(5):688-94. PubMed ID: 26256692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
    Girmenia C; Bertaina A; Piciocchi A; Perruccio K; Algarotti A; Busca A; Cattaneo C; Raiola AM; Guidi S; Iori AP; Candoni A; Irrera G; Milone G; Marcacci G; Scimè R; Musso M; Cudillo L; Sica S; Castagna L; Corradini P; Marchesi F; Pastore D; Alessandrino EP; Annaloro C; Ciceri F; Santarone S; Nassi L; Farina C; Viscoli C; Rossolini GM; Bonifazi F; Rambaldi A;
    Clin Infect Dis; 2017 Nov; 65(11):1884-1896. PubMed ID: 29020286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
    Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
    Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted tongue microbiota and detection of nonindigenous bacteria on the day of allogeneic hematopoietic stem cell transplantation.
    Oku S; Takeshita T; Futatsuki T; Kageyama S; Asakawa M; Mori Y; Miyamoto T; Hata J; Ninomiya T; Kashiwazaki H; Yamashita Y
    PLoS Pathog; 2020 Mar; 16(3):e1008348. PubMed ID: 32150591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Mikulska M; Del Bono V; Prinapori R; Boni L; Raiola AM; Gualandi F; Van Lint MT; Dominietto A; Lamparelli T; Cappellano P; Bacigalupo A; Viscoli C
    Transpl Infect Dis; 2010 Dec; 12(6):505-12. PubMed ID: 20636482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.
    Harada K; Sekiya N; Konishi T; Nagata A; Yamada Y; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Yasuda S; Sasaki S; Yoshioka K; Watakabe-Inamoto K; Igarashi A; Najima Y; Hagino T; Muto H; Kobayashi T; Doki N; Kakihana K; Sakamaki H; Ohashi K
    BMC Infect Dis; 2017 Sep; 17(1):638. PubMed ID: 28938875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.
    Harris B; Morjaria SM; Littmann ER; Geyer AI; Stover DE; Barker JN; Giralt SA; Taur Y; Pamer EG
    Am J Respir Crit Care Med; 2016 Aug; 194(4):450-63. PubMed ID: 26886180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
    Peled JU; Gomes ALC; Devlin SM; Littmann ER; Taur Y; Sung AD; Weber D; Hashimoto D; Slingerland AE; Slingerland JB; Maloy M; Clurman AG; Stein-Thoeringer CK; Markey KA; Docampo MD; Burgos da Silva M; Khan N; Gessner A; Messina JA; Romero K; Lew MV; Bush A; Bohannon L; Brereton DG; Fontana E; Amoretti LA; Wright RJ; Armijo GK; Shono Y; Sanchez-Escamilla M; Castillo Flores N; Alarcon Tomas A; Lin RJ; Yáñez San Segundo L; Shah GL; Cho C; Scordo M; Politikos I; Hayasaka K; Hasegawa Y; Gyurkocza B; Ponce DM; Barker JN; Perales MA; Giralt SA; Jenq RR; Teshima T; Chao NJ; Holler E; Xavier JB; Pamer EG; van den Brink MRM
    N Engl J Med; 2020 Feb; 382(9):822-834. PubMed ID: 32101664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
    Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
    Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.
    Taur Y; Coyte K; Schluter J; Robilotti E; Figueroa C; Gjonbalaj M; Littmann ER; Ling L; Miller L; Gyaltshen Y; Fontana E; Morjaria S; Gyurkocza B; Perales MA; Castro-Malaspina H; Tamari R; Ponce D; Koehne G; Barker J; Jakubowski A; Papadopoulos E; Dahi P; Sauter C; Shaffer B; Young JW; Peled J; Meagher RC; Jenq RR; van den Brink MRM; Giralt SA; Pamer EG; Xavier JB
    Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation.
    Kusakabe S; Fukushima K; Maeda T; Motooka D; Nakamura S; Fujita J; Yokota T; Shibayama H; Oritani K; Kanakura Y
    Br J Haematol; 2020 Feb; 188(3):438-449. PubMed ID: 31566729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.
    Kamboj M; Chung D; Seo SK; Pamer EG; Sepkowitz KA; Jakubowski AA; Papanicolaou G
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1576-81. PubMed ID: 20685257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid.
    Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB
    J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
    Lee YJ; Arguello ES; Jenq RR; Littmann E; Kim GJ; Miller LC; Ling L; Figueroa C; Robilotti E; Perales MA; Barker JN; Giralt S; van den Brink MRM; Pamer EG; Taur Y
    J Infect Dis; 2017 Apr; 215(7):1117-1123. PubMed ID: 28498996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.